A similar block in another pathwaycauseshigh ethylmalonate
A similar block in another pathwaymay causehigh ethylmalonate
red or white meats(passive) contributed byhigh digestibility
to help debugmight be causinghigh stales
wide distribution of ticks in Jeju province(passive) might be caused byHigh seroprevalence
the O incorporationcauseshigh hydrophilicity
a like - minded audience that would enjoydiscoveringHigh Perfumery
by disseminated pyrite in the rock(passive) caused byhigh chargeability
Hay harvestingcauseshigh orthopteran
Coming backto leadHigh Hazels
that the length of the toe.{~inventedhigh heels.{~
the length of the toe.{~inventedhigh heels.{~
sleepinesscan causesleepiness
for hot , warm and cold forgingspecifically designedfor hot , warm and cold forging
the market and procrucially influencedthe market and pro
from more dangerous threadfallresultingfrom more dangerous threadfall
to appended postureleadsto appended posture
to the battery deathleadingto the battery death
to crimeleadsto crime
the increase in operational costcausethe increase in operational cost
in a ratio greater than ten for ( A&Cresultingin a ratio greater than ten for ( A&C
the all metal mode(passive) caused bythe all metal mode
eveninventedeven
to high yieldsleadingto high yields
to the onset of lots of diseasesmay leadto the onset of lots of diseases
poor evaluation for RDF Storescausespoor evaluation for RDF Stores
to obesityleadingto obesity
high currents and the premature aging of LEDscan causehigh currents and the premature aging of LEDs
to hospitalization and sometimes permanent neurological injury or even deathleadingto hospitalization and sometimes permanent neurological injury or even death
in leavingcan contributein leaving
in discontinuation of 6 ( 0.2 % ) participants from therapy in the lovastatin immediate - release group ( n=3,304 ) andresultedin discontinuation of 6 ( 0.2 % ) participants from therapy in the lovastatin immediate - release group ( n=3,304 ) and
in discontinuation of 6 ( 0.2 % ) participants from therapy in the MEVACOR groupresultedin discontinuation of 6 ( 0.2 % ) participants from therapy in the MEVACOR group
in discontinuation of 6resultedin discontinuation of 6
in discontinuation of 6 ( 0.2 % ) participants from therapy in the MEVACOR group ( n=3,304 ) and 4 ( 0.1 % ) in the placebo group ( n=3,301resultedin discontinuation of 6 ( 0.2 % ) participants from therapy in the MEVACOR group ( n=3,304 ) and 4 ( 0.1 % ) in the placebo group ( n=3,301